Study Identifies Four Metabolic Profiles Tied to Different Cancer Trajectories
Researchers mining UK Biobank data expected metabolic disorders to show uniform links to cancer.
Instead, they uncovered four distinct profiles tied to different cancer trajectories, according to a study published Nov. 20 in Nature Communications, according to Entrevue.
The analysis encompassed 405,023 participants, 54.1% women, with a mean age of 56.4 years. Over the follow-up period, 60,909 people — roughly 15% of the cohort — developed a first cancer, and 5,632 of those went on to develop multiple primary cancers.
Scientists examined 25 endocrine, nutritional and metabolic diseases for associations with first cancer onset, multiple primary cancers and mortality. They found the links varied by disease and organ site, arguing against treating metabolic imbalances as a single risk block.
Using statistical methods that mapped co-occurring conditions, the team defined four metabolic profiles. Cluster 1 (C1) centered on iron metabolism disorders and iron deficiency. Cluster 2 (C2) was dominated by type 2 diabetes. Cluster 3 (C3) grouped lipid and lipoprotein metabolism anomalies. Cluster 4 (C4) featured osteoporosis as the predominant condition. The researchers stressed these categories emerged from observed disease associations, not from a single blood test that automatically classifies individuals.
Each profile showed a different pattern of association with cancer occurrence and progression. Some disorders tracked more closely with specific cancer sites; others aligned with more complex trajectories. The team also probed interactions among multiple metabolic diseases within the same person to help explain why people with seemingly comparable health problems can follow divergent paths.
Researchers mined the UK Biobank prospective cohort of 500,000 volunteers recruited across Great Britain from 2006 to 2010, drawing on the more than 10,000 variables held for each participant to define four metabolic profiles linked to distinct cancer trajectories.
Since opening access in 2012, UK Biobank has become a key resource for large-scale health research, with over 30,000 researchers from more than 90 countries registered to use its data and more than 9,000 peer-reviewed publications produced as of November 2023.
To explore biological mechanisms, the scientists analyzed proteins and metabolites and built a predictive model using deep learning across several categories of medical data. The aim is to improve risk estimation by accounting for the complexity of biological interactions rather than relying on isolated factors. The authors cautioned that statistical associations do not prove direct causation and that the identified profiles do not yet constitute clinical diagnostic tools.
Related reading
- Two-Step Routine of Cycling and Brain Games May Help Protect Aging Brain and Ward Off Alzheimer’s
- German, Austrian Officials Call for European TikTok Owner Over Data, Algorithm Control
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)
- Daraxonrasib Stops Tumor Growth in 90.2% of Pancreatic Cancer Patients, Trial Finds (time.news)